Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00480740 · ClinicalTrials.gov registry record · Phase 3
The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
A Phase 3 study, sponsored by Children's National Research Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 41
- Enrollment target
NCT00480740 is a Phase 3 study that has completed, run by Children's National Research Institute. The registered enrollment target is 41 participants.
The verdict
NCT00480740, a Phase 3 study, has completed, sponsored by Children's National Research Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the pharmacokinetics, pharmacodynamics, and pharmacogenomics of dexmedetomidine in the following three pediatric patient populations: patients with bi-directional cavopulmonary anastomosis or a Fontan procedure, patients who have had a cardiac transplant, and patients with otherwise normal physiology who are undergoing closure of a patent ductus arteriosis or atrial septal defect.
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00480740
The ClinicalTrials.gov registry entry for NCT00480740 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT00480740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00480740 about?
NCT00480740 is a clinical study titled "The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease". The purpose of this study is to examine the pharmacokinetics, pharmacodynamics, and pharmacogenomics of dexmedetomidine in the following three pediatric patient populations: patients with bi-directional cavopulmonary anastomosis or a Fontan procedure, patients who have had a cardiac transplant, and ...
What is the current status of trial NCT00480740?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 41 participants. The study started on 2006-12. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00480740?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00480740?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.